Skip to main content
Market intelligence
WHWKSector not reported

Whitehawk Therapeutics, Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Apr 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Apr 16, 2026Scott M. GiacobelloCHIEF FINANCIAL OFFICERSale218,600$4.03$882,029
Apr 14, 2026Bryan BallSee remarksSale118,849$3.60$427,856